OUR TEAM. OUR MISSION.
The QbDVision project was started by two serial entrepreneurs and pharmaceutical manufacturing and quality experts. Our mission is to provide software solutions for the simple application of quality-by-design principles to the development of therapeutics and medical devices reducing development time and reducing the risk of encountering a systemic failure later in the development life cycle.
Rebecca has 18 years of experience in the life science space working with pharmaceuticals, medical devices, biologics, and combination products regulated in the U.S. and Internationally. She has worked with companies such as Genentech, Eli Lilly, Abbott Laboratories, Savara, Xeris, Menarini Silicone Biosystems, Pfizer, J&J and others.
Rebecca was one of the key voices in the development of QbDVision after seeing many pharmaceutical companies struggle with similar problems during product development and commercialization. As a member of our advisory team, she brings her deep experience and enthusiasm to our software development efforts providing the "customer voice" from the perspective of quality, product development, quality operations, and regulatory compliance.
Moj brings over 23 years of experience in the life sciences industry with primary expertise in medical devices and diagnostic technology commercialization and development, regulatory affairs, quality and compliance, research, technical/medical writing, and project management.
As a important member of our advisory team, Moj brings her leadership and management experience in working with medical device and software companies and her deep software validation expertise to the team.
Peter has thirty years of CMC/Regulatory leadership expertise in the Biomedical Industry. Peter has served as Chief Regulatory Officer, Chief Operations Officer, Vice President of CMC and Head of Operations for US-based companies such as Xeris Pharmaceuticals, Jade Therapeutics, Symic Biomedical, BioUtah and Genentech, Inc.
As an influential member of our advisory team, Peter brings his technical and leadership experience in pharmaceutical manufacturing and drug delivery in support of product development efforts.